Latest Alphatec Holdings (ATEC) Headlines
Australia Orthobiologics Market Outlook to 2020
M2 - Thu Mar 06, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/3xqkpc/australia) has announced the addition of the "Australia Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered 1 Table of Contents 2 Introduction 3 Orthobiologics Market, Australia 3.1 Revenue ($m), 2005-2012 3.2 Revenue ($m), 2012-2020 3.3 Volume (Units), 2005-2012 3.4 Volume (Units), 2012-2020 3.5 Australia, Average Price ($), 2005-2020 3.6 Australia, Distribution Share by Revenue ($m), 2011-2012 3.7 Australia, Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in Australia Orthobiologics Market 5 Orthobiologics Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned - Alphatec Holdings. - Australian Biotechnologies - Baxter International - Biomet - DePuy - Medtronic - NuVasive - Sanofi - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/3xqkpc/australia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Alphatec Holdings Down 7.1%, Shares Slide into the Red (ATEC)
Comtex SmarTrend(R) - Mon Mar 03, 10:12AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 7.1% to $1.31 on 1.8x average daily volume. Thus far today, Alphatec Holdings has traded 994,000 shares, vs. average volume of 566,000 shares per day. The stock has underperformed the Dow (-7.1% to the Dow's -0.8%) and underperformed the S&P 500 (-7.1% to the S&P's -0.7%) during today's trading.
Nasdaq stocks posting largest volume increases
AP - Mon Feb 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ORTHOTEC Obtains $73 Million Fraud Verdict Against Publicly Traded Company ALPHATEC (ATEC) Subsidiary Surgiview
GlobeNewswire - Mon Feb 24, 6:30AM CST
Medical device manufacturer OrthoTec, LLC has taken a major step forward in its legal battle against public medical device company ALPHATEC (Nasdaq:ATEC). Following a month-long trial, private company OrthoTec (Los Angeles) obtained a fraud verdict against Surgiview, S.A.S., a subsidiary of public spine company ALPHATEC (ATEC). ALPHATEC (ATEC) is one of the HealthpointCapital portfolio companies, a private equity firm focused on the musculoskeletal sector of the medical device industry. HealthpointCapital is headed by two veterans of private equity investment, Mr. John Foster and Mr. Tim Berkowitz.
Stock to Watch: Alphatec Holdings Down 9.2% (ATEC)
Comtex SmarTrend(R) - Fri Feb 21, 10:41AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 9.2% to $1.48 on 1.3x average daily volume. Thus far today, Alphatec Holdings has traded 451,000 shares, vs. average volume of 339,000 shares per day. The stock has underperformed the Dow (-9.2% to the Dow's 0.2%) and underperformed the S&P 500 (-9.2% to the S&P's 0.3%) during today's trading.
Alphatec Spine Postpones Fourth Quarter and Fiscal Year 2013 Release and Conference Call
GlobeNewswire - Thu Feb 20, 5:00PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it is postponing the release of its financial results for the fourth quarter and fiscal year 2013 and the conference call to discuss the results, both of which were originally scheduled for February 27, 2014. The Company will now release its fourth quarter and fiscal year 2013 financial results on Monday, March 17, 2014 after the close of the market. Details related to this call are outlined below.
10-K: VITRO DIAGNOSTICS INC
Edgar Online - Wed Feb 12, 3:26PM CST
ITEM 7.
Alphatec Holdings Down 14.8%, Shares Slide into the Red (ATEC)
Comtex SmarTrend(R) - Tue Feb 11, 10:12AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 14.8% to $1.95 on 2.0x average daily volume. Thus far today, Alphatec Holdings has traded 470,000 shares, vs. average volume of 232,000 shares per day. The stock has underperformed the Dow (-14.8% to the Dow's 0.5%) and underperformed the S&P 500 (-14.8% to the S&P's 0.4%) during today's trading.
Alphatec Spine Announces Jury Verdict in the OrthoTec Litigation
GlobeNewswire - Tue Feb 11, 8:01AM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that a jury in the OrthoTec, LLC vs. Surgiview S.A.S. case pending before the Superior Court of California, Los Angeles County, reached a verdict. Surgiview, a subsidiary of Scient'x S.A.S., which was acquired by Alphatec in 2010, was found to have transferred assets for less than fair market value in connection with Surgiview's purchase of certain assets of Eurosurgical S.A. in May 2006, and to have interfered with certain contractual rights of OrthoTec.
Alphatec Spine to Release Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Feb 10, 3:00PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, will release its fourth quarter and fiscal year 2013 financial results on Thursday, February 27, 2014 after the close of the market.
Alphatec Holdings (ATEC) Falls: Stock Goes Down 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:58AM CST
Alphatec Holdings, Inc. (ATEC) saw a big move last session, as the company’s shares fell by more than 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $2.11–$2.45 in the past one-month time frame, showed a sharp decline yesterday at $2.30.
Alphatec Holdings (ATEC) Jumps: Stock Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 8:39AM CST
Alphatec Holdings, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
Stock to Watch: Alphatec Holdings Up 8.9% (ATEC)
Comtex SmarTrend(R) - Thu Feb 06, 10:41AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's best performing low-priced stocks, up 8.9% to $2.45 on 1.3x average daily volume. Thus far today, Alphatec Holdings has traded 281,000 shares, vs. average volume of 222,000 shares per day. The stock has outperformed the Dow (8.9% to the Dow's 0.9%) and outperformed the S&P 500 (8.9% to the S&P's 0.9%) during today's trading.
HSIC to Buy 5 Healthcare Biz in Europe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 2:20PM CST
Henry Schein expands its presence in Europe, significantly, with plans to undertake five acquisitions in the region.
Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 8:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Tuesday
Alphatec Spine Announces Executive Leadership Changes
GlobeNewswire - Thu Jan 02, 3:05PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced that Mike Plunkett will succeed Pat Ryan as Chief Operating Officer. Mr. Ryan, who has led Alphatec Spine's global operations since 2011, has announced his intention to resign from the company to pursue other opportunities.
Alphatec Spine to Present at 24th Annual Oppenheimer Healthcare Conference
GlobeNewswire - Mon Nov 25, 2:37PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 2013 Oppenheimer Healthcare Conference on Wednesday, December 11, 2013 at 8:55 AM Eastern Time at the Crowne Plaza Times Square, New York.
Alphatec Spine to Present at 25th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 19, 11:16AM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 2013 Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 3:00 PM Eastern Time at the New York Palace Hotel.
Time to Buy Alphatec Holdings Inc. (ATEC) After Recent Moving Average Crossover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 6:21AM CST
Time to Buy Alphatec Holdings Inc. (ATEC) After Recent Moving Average Crossover?
Alphatec Spine Reports Third Quarter 2013 Financial Results
GlobeNewswire - Thu Nov 07, 3:05PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced its financial results for the third quarter of fiscal year 2013, ended September 30, 2013.
Australia Orthobiologics Market Outlook to 2020
M2 - Thu Mar 06, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/3xqkpc/australia) has announced the addition of the "Australia Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered 1 Table of Contents 2 Introduction 3 Orthobiologics Market, Australia 3.1 Revenue ($m), 2005-2012 3.2 Revenue ($m), 2012-2020 3.3 Volume (Units), 2005-2012 3.4 Volume (Units), 2012-2020 3.5 Australia, Average Price ($), 2005-2020 3.6 Australia, Distribution Share by Revenue ($m), 2011-2012 3.7 Australia, Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in Australia Orthobiologics Market 5 Orthobiologics Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned - Alphatec Holdings. - Australian Biotechnologies - Baxter International - Biomet - DePuy - Medtronic - NuVasive - Sanofi - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/3xqkpc/australia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Alphatec Holdings Down 7.1%, Shares Slide into the Red (ATEC)
Comtex SmarTrend(R) - Mon Mar 03, 10:12AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 7.1% to $1.31 on 1.8x average daily volume. Thus far today, Alphatec Holdings has traded 994,000 shares, vs. average volume of 566,000 shares per day. The stock has underperformed the Dow (-7.1% to the Dow's -0.8%) and underperformed the S&P 500 (-7.1% to the S&P's -0.7%) during today's trading.
Nasdaq stocks posting largest volume increases
AP - Mon Feb 24, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ORTHOTEC Obtains $73 Million Fraud Verdict Against Publicly Traded Company ALPHATEC (ATEC) Subsidiary Surgiview
GlobeNewswire - Mon Feb 24, 6:30AM CST
Medical device manufacturer OrthoTec, LLC has taken a major step forward in its legal battle against public medical device company ALPHATEC (Nasdaq:ATEC). Following a month-long trial, private company OrthoTec (Los Angeles) obtained a fraud verdict against Surgiview, S.A.S., a subsidiary of public spine company ALPHATEC (ATEC). ALPHATEC (ATEC) is one of the HealthpointCapital portfolio companies, a private equity firm focused on the musculoskeletal sector of the medical device industry. HealthpointCapital is headed by two veterans of private equity investment, Mr. John Foster and Mr. Tim Berkowitz.
Stock to Watch: Alphatec Holdings Down 9.2% (ATEC)
Comtex SmarTrend(R) - Fri Feb 21, 10:41AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 9.2% to $1.48 on 1.3x average daily volume. Thus far today, Alphatec Holdings has traded 451,000 shares, vs. average volume of 339,000 shares per day. The stock has underperformed the Dow (-9.2% to the Dow's 0.2%) and underperformed the S&P 500 (-9.2% to the S&P's 0.3%) during today's trading.
Alphatec Spine Postpones Fourth Quarter and Fiscal Year 2013 Release and Conference Call
GlobeNewswire - Thu Feb 20, 5:00PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it is postponing the release of its financial results for the fourth quarter and fiscal year 2013 and the conference call to discuss the results, both of which were originally scheduled for February 27, 2014. The Company will now release its fourth quarter and fiscal year 2013 financial results on Monday, March 17, 2014 after the close of the market. Details related to this call are outlined below.
10-K: VITRO DIAGNOSTICS INC
Edgar Online - Wed Feb 12, 3:26PM CST
ITEM 7.
Alphatec Holdings Down 14.8%, Shares Slide into the Red (ATEC)
Comtex SmarTrend(R) - Tue Feb 11, 10:12AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's worst performing low-priced stocks, down 14.8% to $1.95 on 2.0x average daily volume. Thus far today, Alphatec Holdings has traded 470,000 shares, vs. average volume of 232,000 shares per day. The stock has underperformed the Dow (-14.8% to the Dow's 0.5%) and underperformed the S&P 500 (-14.8% to the S&P's 0.4%) during today's trading.
Alphatec Spine Announces Jury Verdict in the OrthoTec Litigation
GlobeNewswire - Tue Feb 11, 8:01AM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that a jury in the OrthoTec, LLC vs. Surgiview S.A.S. case pending before the Superior Court of California, Los Angeles County, reached a verdict. Surgiview, a subsidiary of Scient'x S.A.S., which was acquired by Alphatec in 2010, was found to have transferred assets for less than fair market value in connection with Surgiview's purchase of certain assets of Eurosurgical S.A. in May 2006, and to have interfered with certain contractual rights of OrthoTec.
Alphatec Spine to Release Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Feb 10, 3:00PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, will release its fourth quarter and fiscal year 2013 financial results on Thursday, February 27, 2014 after the close of the market.
Alphatec Holdings (ATEC) Falls: Stock Goes Down 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:58AM CST
Alphatec Holdings, Inc. (ATEC) saw a big move last session, as the company’s shares fell by more than 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $2.11–$2.45 in the past one-month time frame, showed a sharp decline yesterday at $2.30.
Alphatec Holdings (ATEC) Jumps: Stock Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 8:39AM CST
Alphatec Holdings, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
Stock to Watch: Alphatec Holdings Up 8.9% (ATEC)
Comtex SmarTrend(R) - Thu Feb 06, 10:41AM CST
Alphatec Holdings (NASDAQ:ATEC) is one of today's best performing low-priced stocks, up 8.9% to $2.45 on 1.3x average daily volume. Thus far today, Alphatec Holdings has traded 281,000 shares, vs. average volume of 222,000 shares per day. The stock has outperformed the Dow (8.9% to the Dow's 0.9%) and outperformed the S&P 500 (8.9% to the S&P's 0.9%) during today's trading.
HSIC to Buy 5 Healthcare Biz in Europe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 2:20PM CST
Henry Schein expands its presence in Europe, significantly, with plans to undertake five acquisitions in the region.
Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 8:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Tuesday
Alphatec Spine Announces Executive Leadership Changes
GlobeNewswire - Thu Jan 02, 3:05PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced that Mike Plunkett will succeed Pat Ryan as Chief Operating Officer. Mr. Ryan, who has led Alphatec Spine's global operations since 2011, has announced his intention to resign from the company to pursue other opportunities.
Alphatec Spine to Present at 24th Annual Oppenheimer Healthcare Conference
GlobeNewswire - Mon Nov 25, 2:37PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 2013 Oppenheimer Healthcare Conference on Wednesday, December 11, 2013 at 8:55 AM Eastern Time at the Crowne Plaza Times Square, New York.
Alphatec Spine to Present at 25th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 19, 11:16AM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 2013 Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 3:00 PM Eastern Time at the New York Palace Hotel.
Time to Buy Alphatec Holdings Inc. (ATEC) After Recent Moving Average Crossover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 6:21AM CST
Time to Buy Alphatec Holdings Inc. (ATEC) After Recent Moving Average Crossover?
Alphatec Spine Reports Third Quarter 2013 Financial Results
GlobeNewswire - Thu Nov 07, 3:05PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced its financial results for the third quarter of fiscal year 2013, ended September 30, 2013.
